1. THE APP THAT ALLOWS EVERY DOCTOR TO PRACTICE:
HCV THERAPY SELECTOR
THE APP THAT ALLOWS EVERY DOCTOR TO PRACTICE:
EVIDENCE BASED MEDICINE WITHIN 1 MINUTE
SHARED DECISION MAKING

2. Public health problems Hepatitis C
Mortality of chronic hepatitis C
Guidelines anno 2017
High mortality About 500 Dutch patients a year die from liver diseases caused by a hepatitis infection. Effective treatments The deaths are "largely avoidable", because effective treatments against hepatitis B and C are available . Lack of awareness There is no other known infectious disease in the Netherlands of which so many people die year after year, except possibly influenza.
Quality usually good Evidence based (AASLD) or expert-based (EASL)
Therapy Selection? Therapeutic options presented without success rates: how to choose the option that fits your patient?
Penetration expert hepatology centers: good general hospitals: poor general practitioners: poor patients: poor

3. What is HCV Therapy Selector?
Guideline
recommendations
for patient profiles based on genotype, previous treatment history and cirrhosis stage
Evidenced-based
chance of cure:
for 80 patient profiles of hepatitis C infection
Treatment specific
Information
about side effects, cost and reimbursement
Everywhere within 1 minute available:
Patient-profile tailored information to facilitate selection of the best fitting treatment
What is HCV Therapy Selector?

4. HCV Therapy Selector complements guidelines1
Guideline recommendations are expert-based, variably evidenced-based.
Guideline recommendations do not give crucial information about the cure rate to be expected.
Searching patient-specific guideline information takes time
Guideline recommendation give many therapeutic options. It is usually unclear which is best fitting your patient with regard to cure rate, adverse-effects and costs.
Guideline recommendations due to its size, physician jargon, and complexity do not facilitate shared decision making. 1
Patient profile data are evidence-based
Patient-profile data inform about the chance of cure, and provides treatment-specific information on cost
Searching patient-specific profile data takes less than 1 minute.
Patient-profile data information give many therapeutic options. It is usually clear which is best fitting your patient with regard to cure rate, adverse-effects and costs.
Patient-profile data information due to its simplicity and easy accessibility facilitates shared decision making 2 2 3 3 4 4 5 5

5. Trend 2017 Individualizing HCV Therapy !
How do I do that?

6. Added value of HCV Therapy Selector: Tool to individualize HCV Therapy
Evidenced-based
chance of cure:
of all published treatment regimens
Context-based
Rx selection
Patient preference: side effects, efficacy. Doctor preference: experience, pathophysiology.
Information available within 1 minute :
Smartphone app Patient profile selection: 5 clicks
Treatment selection: 5 clicks